TAD Pharma GmbH
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ESOMEPRAZOLE TAD gastro-resistant capsule, hard 20 mg
- ESOMEPRAZOLE TAD gastro-resistant capsule, hard 40 mg
- PANTOPRAZOLE TAD gastro-resistant tablet 20 mg
- PANTOPRAZOLE TAD gastro-resistant tablet 40 mg
- B01 - Agentes antitrombóticos
- CLOPIDOGREL TAD film-coated tablet 75 mg
- C07 - Betabloqueantes
- BLOXAZOC prolonged-release tablet 100 mg
- BLOXAZOC prolonged-release tablet 200 mg
- BLOXAZOC prolonged-release tablet 25 mg
- BLOXAZOC prolonged-release tablet 50 mg
- C08 - Bloqueantes del canal de calcio
- AMLOBE tablet 10 mg
- AMLOBE tablet 5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- CANDESARTAN TAD tablet 16 mg
- CANDESARTAN TAD tablet 32 mg
- OLMESARTAN HYDROCHLOROTHIAZIDE TAD film-coated tablet 20 mg+12.5 mg
- OLMESARTAN TAD film-coated tablet 10 mg
- OLMESARTAN TAD film-coated tablet 20 mg
- OLMESARTAN TAD film-coated tablet 40 mg
- C10 - Agentes modificadores de los lípidos
- ROSUVADOR film-coated tablet 10 mg
- ROSUVADOR film-coated tablet 20 mg
- ROSUVADOR film-coated tablet 40 mg
- ROSUVADOR film-coated tablet 5 mg
- N06 - Psicoanalépticos
- VENLAFAXIN TAD prolonged-release capsule, hard 150 mg
- VENLAFAXIN TAD prolonged-release capsule, hard 75 mg